Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of use

Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of use

US Patent 10604561 · Granted Mar 31, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cross-species anti-latent TGF-beta 1 antibodies and methods of use2025
Anti-sclerostin antibodies and methods of use2025
Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and me2025
Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and me2025
Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and me2025
Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and me2025
Anti-dengue virus antibodies having cross-reactivity to Zika virus and methods o2024
Anti-dengue virus antibodies having cross-reactivity to Zika virus and methods o2024
Anti-dengue virus antibodies, polypeptides containing variant FC regions, and me2023
Anti-dengue virus antibodies, polypeptides containing variant FC regions, and me2023
Anti-dengue virus antibodies, polypeptides containing variant FC regions, and me2023
Anti-dengue virus antibodies, polypeptides containing variant FC regions, and me2023